Serina Therapeutics, Inc.

SERAMEXHealthcare● Active

$1.92

+$0.02(+1.05%)

Market Cap$20799999

P/E Ratio—

52W High$7.92

52W Low$1.22

Avg Volume3.2M

Open$1.90

Beta0.10

Overview

Serina Therapeutics, Inc. (SER) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ser · stock forecast · 1 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 1 Wall Street analysts in the past 3 months

Buy

1 analysts

consensus

Rating Breakdown

Strong Buy

Buy

Hold

Sell

Strong Sell

Total: 1 · Buy rate: 100.0%

12-Month Price Target

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $1.90

The Serina Therapeutics, Inc. (SER) analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month SER price target is $0.00, representing +0.0% upside from the current price of $1.90.

Short-Term Price Prediction

Algorithmically generated · Updated daily

Date	Predicted Price	Change	Min	Max
2026-06-10	$1.95	↑ 2.58%	$1.93	$1.97

1-day model range: $1.93–$1.97. Peak: $1.97 (+2.58%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%36%14%

7Buy

5Neutral

2Sell

RSI (14)67.3Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · SER · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$1.84BUY

MA 10$1.85BUY

MA 20$1.77BUY

MA 50$1.88BUY

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $SER · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$1.86BUY

EMA 10$1.84BUY

EMA 20$1.83BUY

EMA 50$1.95SELL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $SER · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:

Date	Brokerage	Action	Rating
2025-08-28	HC Wainwright & Co.	Maintains	Buy→Buy

HC Wainwright & Co.2025-08-28

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on Serina Therapeutics, Inc. (SER) stock. Of the recent 1 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover SER.

Analyst Recommendation Trends

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

SER analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$0M

Revenue Next Year

$0M

EPS This Year

$-1.84

EPS Next Year

$-1.26

↓ 31.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SER EPS of $-1.84 for the current fiscal year, based on estimates from 1 analysts. The SER revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SER stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SER price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.

The SER short-term stock prediction for tomorrow is $1.95 (+2.58%).

Serina Therapeutics, Inc. trades on AMEX under the ticker SER. The SER stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Earnings Revenue PE Ratio Financials Market Cap Insider Trades Dividends Price History

Frequently asked questions

SER forecast · 8 questions

According to 1 Wall Street analysts, the average 12-month SER price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.90.

SER price targetWhat is SER price targetSER analyst price targetSER 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.